Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-24

Clinical Trial Update: Efficacy and Safety of Polyene Phosphatidylcholine in Treatment of Patients With Acute Drug-induced Liver Injury [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing efficacy and safety of polyene phosphatidylcholine for acute drug-induced liver injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyene phosphatidylcholine (polyene phosphatidylcholine)

Snippet

Sponsor: Sichuan Haisco Pharmaceutical Group Co., Ltd | Conditions: Acute Drug Induced Liver Injury | Phase 4 | Status: COMPLETED